• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Coverage

Latest content

Antti Siltanen

Analyst

Antti Siltanen portrait

Coverage

Herantis PharmaNexstimFaron PharmaceuticalsNightingale HealthBioretecAiforia TechnologiesBiohitOrionModulight

Latest content

ShowingAll content types

Biohit: GastroPanel Quick Test also works during proton pump inhibitor therapy

Analyst Comment 2026-08-19 08:27 by Antti Siltanen
Biohit

Nightingale's remote tests to be included in Supernormal's weight loss service

Analyst Comment 2026-08-19 09:12 by Antti Siltanen
Nightingale Health

Modulight Q2'26 preview: Savings measures likely to improve earnings while revenue declines

Analyst Comment 2026-08-19 09:22 by Antti Siltanen
Modulight

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account

Herantis H1'26 preview: Focus on Phase IIa preparations and funding

Analyst Comment 2026-08-18 08:01 by Antti Siltanen
Herantis Pharma

New partnership for Nightingale in the UK

Analyst Comment 2026-08-18 09:18 by Antti Siltanen
Nightingale Health

Nexstim H1'26: Brainlab potential to be weighed later this year

Research 2026-08-17 09:09 by Antti Siltanen
Nexstim

Bioretec Q2'26: There is growth, but the trend is not yet clear

Research 2026-08-14 10:03 by Antti Siltanen
Bioretec

Bioretec H1'26: Expansion of the product portfolio into spinal applications progresses

Video 2026-08-13 13:16 by Antti Siltanen
Bioretec

Orion: Motgång i fas 3-studien för levosimendan

Analyst Comment 2026-08-11 07:12 by Antti Siltanen
Orion

Nexstim H1'26 preview: Our expectations for the beginning of the year are moderate

Analyst Comment 2026-08-11 08:25 by Antti Siltanen
Nexstim